1. Home
  2. TNC vs NTLA Comparison

TNC vs NTLA Comparison

Compare TNC & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNC
  • NTLA
  • Stock Information
  • Founded
  • TNC 1870
  • NTLA 2014
  • Country
  • TNC United States
  • NTLA United States
  • Employees
  • TNC N/A
  • NTLA N/A
  • Industry
  • TNC Industrial Machinery/Components
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • TNC Industrials
  • NTLA Health Care
  • Exchange
  • TNC Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • TNC 1.4B
  • NTLA 1.2B
  • IPO Year
  • TNC N/A
  • NTLA 2016
  • Fundamental
  • Price
  • TNC $82.09
  • NTLA $11.36
  • Analyst Decision
  • TNC Strong Buy
  • NTLA Buy
  • Analyst Count
  • TNC 1
  • NTLA 20
  • Target Price
  • TNC $125.00
  • NTLA $32.30
  • AVG Volume (30 Days)
  • TNC 107.1K
  • NTLA 4.3M
  • Earning Date
  • TNC 08-06-2025
  • NTLA 08-07-2025
  • Dividend Yield
  • TNC 1.44%
  • NTLA N/A
  • EPS Growth
  • TNC N/A
  • NTLA N/A
  • EPS
  • TNC 3.20
  • NTLA N/A
  • Revenue
  • TNC $1,253,300,000.00
  • NTLA $52,857,000.00
  • Revenue This Year
  • TNC N/A
  • NTLA $8.32
  • Revenue Next Year
  • TNC $3.88
  • NTLA N/A
  • P/E Ratio
  • TNC $25.60
  • NTLA N/A
  • Revenue Growth
  • TNC N/A
  • NTLA 14.99
  • 52 Week Low
  • TNC $67.32
  • NTLA $5.90
  • 52 Week High
  • TNC $98.52
  • NTLA $23.76
  • Technical
  • Relative Strength Index (RSI)
  • TNC 49.96
  • NTLA 52.35
  • Support Level
  • TNC $81.65
  • NTLA $9.82
  • Resistance Level
  • TNC $83.99
  • NTLA $11.95
  • Average True Range (ATR)
  • TNC 1.75
  • NTLA 0.51
  • MACD
  • TNC -0.09
  • NTLA 0.07
  • Stochastic Oscillator
  • TNC 31.60
  • NTLA 72.07

About TNC Tennant Company

Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: